Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)2020-08-262020-08-262020-03EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2020, 'Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006', EFSA Journal, vol. 18, no. 3, e06004, pp. e06004. https://doi.org/10.2903/j.efsa.2020.60041831-4732ORCID: /0000-0002-9275-9713/work/99981911https://hdl.handle.net/2164/14999161820045enggingivitisgum functionhealth claimL. reuteri ATCC PTA 5289L. reuteri DSM 17938GINGIVITISCOLONIZATIONEXPOSUREQ ScienceFood ScienceAnimal Science and Zoologyveterinary (miscalleneous)Plant ScienceParasitologyMicrobiologyQOrodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006Journal article10.2903/j.efsa.2020.6004http://www.scopus.com/inward/record.url?scp=85081929700&partnerID=8YFLogxK183